United States

People: Mylan NV (MYL.O)

MYL.O on Nasdaq

20 Oct 2017
Change (% chg)

$0.22 (+0.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Parrish, Mark 

Mr. Mark W. Parrish is Non-Executive Independent Director of Mylan Inc. He has served as Chairman and Chief Executive Officer of TridentUSA Health Services, a provider of mobile X-ray and laboratory services to the long-term care industry, since 2008. Since January 2013, Mr. Parrish has also served on the Board of Directors of Omnicell, Inc. (NASDAQ: OMCL), a company that specializes in healthcare technology. Mr. Parrish also serves on the Boards of Directors of Silvergate Pharmaceuticals, a private company that develops and commercializes pediatric medications, and GSMS, a private company that specializes in meeting unique labeling and sizing needs for its customers and pharmaceutical packaging, serialization, and distribution. From 2001 to 2007, Mr. Parrish held management roles of increasing responsibility with Cardinal Health Inc. (NYSE: CAH) and its affiliates, including Chief Executive Officer of Healthcare Supply Chain Services for Cardinal Health from 2006 to 2007. Mr. Parrish also serves as President of the International Federation of Pharmaceutical Wholesalers, an association of pharmaceutical wholesalers and pharmaceutical supply chain service companies, and senior adviser to Frazier Healthcare Ventures, a healthcare oriented growth equity firm.

Basic Compensation

Total Annual Compensation, USD 145,000
Restricted Stock Awards, USD 165,050
Long-Term Incentive Plans, USD --
All Other, USD 70,529
Fiscal Year Total, USD 380,579

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Coury


Rajiv Malik


Heather Bresch


Kenneth Parks


Dennis Zeleny


Daniel Gallagher

As Of  30 Dec 2015